Insider trades
Noubar Afeyan, Director of Moderna MRNA, has filed 11 purchases and 234 sales on the open market. Over the past 12 months that comes to a net purchase of $148.9M. The latest trade was on 05/21.
Noubar Afeyan
Director
- Company
- Moderna MRNA
- First filing
- 23/01/13
- Trades
- 300 trades
- Buys / sales
- 11 / 234
- 12-month net buying
- $148.9M
- Last trade
- 05/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ModernaMRNA | Open-market sale | 05/21 | 05/22 | 9,263 sh | $46.84 | $433,878.92 | −70.2% |
GENB | Open-market buy | 03/02 | 03/02 | 9,375,000 sh6 trades | $16.00avg. | $150,000,000 | No record |
ModernaMRNA | Open-market sale | 25/12/11 | 25/12/15 | 23,853 sh | $29.49 | $703,424.97 | −85.9% |
MRNA | Open-market sale10b5-1 plan | 24/07/31 | 24/08/02 | 15,000 sh4 trades | $119.96avg. | $1,799,448.02 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/07/24 | 24/07/26 | 15,000 sh4 trades | $117.80avg. | $1,766,989.04 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/07/17 | 24/07/19 | 15,000 sh5 trades | $122.84avg. | $1,842,645.04 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/07/10 | 24/07/12 | 15,000 sh5 trades | $117.08avg. | $1,756,183.43 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/06/26 | 24/06/28 | 15,000 sh10 trades | $127.22avg. | $1,908,316.5 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/06/18 | 24/06/21 | 15,000 sh5 trades | $133.57avg. | $2,003,527.2 | −0.6% |
MRNA | Open-market sale10b5-1 plan | 24/06/12 | 24/06/14 | 15,000 sh8 trades | $147.20avg. | $2,208,062.6 | −0.6% |
MRNA | Open-market sale | 24/06/11 | 24/06/11 | 202,832 sh4 trades | $148.33avg. | $30,086,451 | −11.7% |
MRNA | Open-market sale10b5-1 plan | 24/06/05 | 24/06/07 | 15,000 sh9 trades | $151.25avg. | $2,268,817.68 | −0.8% |
MRNA | Open-market sale10b5-1 plan | 24/05/29 | 24/05/31 | 20,000 sh8 trades | $145.08avg. | $2,901,616.51 | −1.0% |
MRNA | Open-market sale10b5-1 plan | 24/05/22 | 24/05/24 | 15,000 sh19 trades | $157.57avg. | $2,363,544.97 | −0.8% |
MRNA | Open-market sale10b5-1 plan | 24/05/15 | 24/05/17 | 15,000 sh5 trades | $127.33avg. | $1,909,912.51 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/05/08 | 24/05/10 | 15,000 sh3 trades | $121.68avg. | $1,825,248.08 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/05/01 | 24/05/03 | 15,000 sh5 trades | $110.92avg. | $1,663,841.94 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/04/24 | 24/04/26 | 15,000 sh4 trades | $108.32avg. | $1,624,868.58 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/04/17 | 24/04/19 | 15,000 sh3 trades | $103.38avg. | $1,550,712.23 | −0.7% |
MRNA | Open-market sale10b5-1 plan | 24/04/10 | 24/04/12 | 15,000 sh4 trades | $107.12avg. | $1,606,809.73 | −0.7% |
